WO2008105497A1 - ベンゾイミダゾール化合物およびその医薬用途 - Google Patents
ベンゾイミダゾール化合物およびその医薬用途 Download PDFInfo
- Publication number
- WO2008105497A1 WO2008105497A1 PCT/JP2008/053524 JP2008053524W WO2008105497A1 WO 2008105497 A1 WO2008105497 A1 WO 2008105497A1 JP 2008053524 W JP2008053524 W JP 2008053524W WO 2008105497 A1 WO2008105497 A1 WO 2008105497A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pharmaceutical use
- benzimidazole compound
- orl
- receptor agonist
- disclosed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2679530A CA2679530C (en) | 2007-03-01 | 2008-02-28 | Benzimidazole compound and pharmaceutical use thereof |
AU2008219980A AU2008219980B2 (en) | 2007-03-01 | 2008-02-28 | Benzimidazole compound and pharmaceutical use thereof |
KR1020097020508A KR101165504B1 (ko) | 2007-03-01 | 2008-02-28 | 벤조이미다졸 화합물 및 그의 의약 용도 |
EP08712095.2A EP2128154B1 (en) | 2007-03-01 | 2008-02-28 | Benzimidazole compound and pharmaceutical use thereof |
JP2009501298A JP5313865B2 (ja) | 2007-03-01 | 2008-02-28 | ベンゾイミダゾール化合物およびその医薬用途 |
ES08712095.2T ES2541133T3 (es) | 2007-03-01 | 2008-02-28 | Compuesto de bencimidazol y uso farmacéutico del mismo |
MX2009009355A MX2009009355A (es) | 2007-03-01 | 2008-02-28 | Compuesto de bencimidazol y uso farmaceutico del mismo. |
US12/449,874 US8877779B2 (en) | 2007-03-01 | 2008-02-28 | Benzimidazole compound and pharmaceutical use thereof |
BRPI0808025-9A2A BRPI0808025A2 (pt) | 2007-03-01 | 2008-02-28 | Composto de benzimidazol e uso farmacêutico do mesmo |
CN2008800068312A CN101622241B (zh) | 2007-03-01 | 2008-02-28 | 苯并咪唑化合物及其医药用途 |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007051842 | 2007-03-01 | ||
JP2007-051842 | 2007-03-01 | ||
JP2007-059260 | 2007-03-08 | ||
JP2007059260 | 2007-03-08 | ||
JP2007-078845 | 2007-03-26 | ||
JP2007078845 | 2007-03-26 | ||
JP2007-093846 | 2007-03-30 | ||
JP2007093846 | 2007-03-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008105497A1 true WO2008105497A1 (ja) | 2008-09-04 |
Family
ID=39721321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/053524 WO2008105497A1 (ja) | 2007-03-01 | 2008-02-28 | ベンゾイミダゾール化合物およびその医薬用途 |
Country Status (11)
Country | Link |
---|---|
US (1) | US8877779B2 (ja) |
EP (1) | EP2128154B1 (ja) |
JP (2) | JP5313865B2 (ja) |
KR (1) | KR101165504B1 (ja) |
CN (1) | CN101622241B (ja) |
AU (1) | AU2008219980B2 (ja) |
BR (1) | BRPI0808025A2 (ja) |
CA (1) | CA2679530C (ja) |
ES (1) | ES2541133T3 (ja) |
MX (1) | MX2009009355A (ja) |
WO (1) | WO2008105497A1 (ja) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009027820A3 (en) * | 2007-08-31 | 2009-04-23 | Purdue Pharma Lp | Substituted-quinoxaline-type-piperidine compounds and the uses thereof |
WO2010090198A1 (ja) | 2009-02-03 | 2010-08-12 | 田辺三菱製薬株式会社 | 1-(4-ピペリジニル)ベンゾイミダゾロン誘導体の製造方法 |
US8471032B2 (en) | 2008-09-16 | 2013-06-25 | Mitsubishi Tanabe Pharma Corporation | Benzimidazole compound in crystal form and salt thereof |
JP2015010072A (ja) * | 2013-06-28 | 2015-01-19 | 三菱瓦斯化学株式会社 | テトラリン骨格を有する新規アルデヒド、およびその製造方法。 |
US9656994B2 (en) | 2013-03-22 | 2017-05-23 | The Scripps Research Institute | Substituted benzimidazoles as nociceptin receptor modulators |
WO2018097291A1 (ja) | 2016-11-28 | 2018-05-31 | 田辺三菱製薬株式会社 | コカイン依存症の治療または再発予防薬 |
US10246465B2 (en) | 2014-06-02 | 2019-04-02 | Laboratorios Del Dr. Esteve S.A. | Alkyl derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against pain |
US10689398B2 (en) | 2015-10-23 | 2020-06-23 | Esteve Pharmaceuticals, S.A. | OXA-Diazaspiro compounds having activity against pain |
US10703765B2 (en) | 2014-06-02 | 2020-07-07 | Esteve Pharmaceuticals, S.A. | Alkyl and aryl derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against pain |
US10927128B2 (en) | 2015-11-16 | 2021-02-23 | Esteve Pharmaceuticals. S.A. | Oxadiazaspiro compounds for the treatment of drug abuse and addiction |
US11236110B2 (en) | 2017-10-17 | 2022-02-01 | Esteve Pharmaceuticals, S.A. | Salts of (R)-9-(2,5-difluorophenethyl)-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR072578A1 (es) * | 2008-07-21 | 2010-09-08 | Purdue Pharma Lp | Compuestos de piperidina puenteada tipo quinoxalina sustituida y los usos de los mismos |
TW201607923A (zh) | 2014-07-15 | 2016-03-01 | 歌林達有限公司 | 被取代之氮螺環(4.5)癸烷衍生物 |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10212290A (ja) | 1997-01-30 | 1998-08-11 | F Hoffmann La Roche Ag | 8−置換−1,3,8−トリアザ−スピロ〔4.5〕デカン−4−オン誘導体 |
WO1998054168A1 (fr) | 1997-05-30 | 1998-12-03 | Banyu Pharmaceutical Co., Ltd. | Derives de 2-0xoimidazole |
WO1999036421A1 (en) | 1998-01-19 | 1999-07-22 | Pfizer Pharmaceuticals Inc. | 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists |
JPH11228575A (ja) | 1997-12-05 | 1999-08-24 | F Hoffmann La Roche Ag | 1,3,8−トリアザ−スピロ〔4.5〕デカン−4−オン誘導体 |
JP2000026466A (ja) | 1998-06-12 | 2000-01-25 | F Hoffmann La Roche Ag | ジ―又はトリアザ―スピロ〔4,5〕デカン誘導体 |
WO2001039775A1 (en) | 1999-12-06 | 2001-06-07 | Euro-Celtique, S.A. | Benzimidazole compounds having nociceptin receptor affinity |
WO2003082333A1 (fr) | 2002-03-29 | 2003-10-09 | Mitsubishi Pharma Corporation | Remede contre les troubles du sommeil |
WO2005028466A1 (en) | 2003-09-25 | 2005-03-31 | Solvay Pharmaceuticals B.V. | Benzimidazolone and quinazolinone derivatives as agonists on human orl1 receptors |
WO2006000545A1 (de) | 2004-06-23 | 2006-01-05 | Siemens Aktiengesellschaft | Aufbau einer verbindung für den austausch von daten eines ip-basierten dienstes |
JP2007051842A (ja) | 2005-08-19 | 2007-03-01 | Nippon Mizushori Giken:Kk | プラント洗浄方法,アスベスト除去方法および解体処理方法並びにミスト発生機 |
JP2007059260A (ja) | 2005-08-25 | 2007-03-08 | Toshiba Lighting & Technology Corp | 照明装置及び照明器具 |
JP2007078845A (ja) | 2005-09-12 | 2007-03-29 | Sharp Corp | 現像装置およびそれを備える画像形成装置 |
JP2007093846A (ja) | 2005-09-28 | 2007-04-12 | Sanyo Epson Imaging Devices Corp | 電気光学装置、および電子機器 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0963987B1 (en) | 1998-06-12 | 2002-08-28 | F. Hoffmann-La Roche Ag | Spiro(piperidine-4,1'-pyrrolo(3,4-c)pyrrole) |
US6262066B1 (en) | 1998-07-27 | 2001-07-17 | Schering Corporation | High affinity ligands for nociceptin receptor ORL-1 |
ID29137A (id) * | 1998-07-27 | 2001-08-02 | Schering Corp | Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1 |
AU8657398A (en) | 1998-07-30 | 2000-02-21 | Picower Institute For Medical Research, The | Immunotherapeutic anti-cancer pharmaceutical compositions |
SI1598340T1 (sl) * | 2001-04-18 | 2009-08-31 | Euro Celtique Sa | Derivati 1-(4-piperidinil)-1,3-dihidro-2H-benzoksazol-2-ona in sorodne spojine kot analogi nociceptina in ligandi ORL1 za zdravljenje bolečine |
US20030226657A1 (en) * | 2002-04-01 | 2003-12-11 | Wallace Thomas E. | Food delivery system and method for storing and heating food to a serving temperature |
CN1856485A (zh) * | 2003-09-25 | 2006-11-01 | 索尔瓦药物有限公司 | 作为人orl1受体激动剂的苯并咪唑酮和喹唑啉酮衍生物 |
-
2008
- 2008-02-28 AU AU2008219980A patent/AU2008219980B2/en not_active Ceased
- 2008-02-28 EP EP08712095.2A patent/EP2128154B1/en not_active Not-in-force
- 2008-02-28 CA CA2679530A patent/CA2679530C/en not_active Expired - Fee Related
- 2008-02-28 BR BRPI0808025-9A2A patent/BRPI0808025A2/pt not_active IP Right Cessation
- 2008-02-28 US US12/449,874 patent/US8877779B2/en active Active
- 2008-02-28 WO PCT/JP2008/053524 patent/WO2008105497A1/ja active Application Filing
- 2008-02-28 ES ES08712095.2T patent/ES2541133T3/es active Active
- 2008-02-28 JP JP2009501298A patent/JP5313865B2/ja not_active Expired - Fee Related
- 2008-02-28 MX MX2009009355A patent/MX2009009355A/es not_active Application Discontinuation
- 2008-02-28 KR KR1020097020508A patent/KR101165504B1/ko active IP Right Grant
- 2008-02-28 CN CN2008800068312A patent/CN101622241B/zh not_active Expired - Fee Related
-
2013
- 2013-03-11 JP JP2013048087A patent/JP2013107910A/ja not_active Abandoned
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10212290A (ja) | 1997-01-30 | 1998-08-11 | F Hoffmann La Roche Ag | 8−置換−1,3,8−トリアザ−スピロ〔4.5〕デカン−4−オン誘導体 |
WO1998054168A1 (fr) | 1997-05-30 | 1998-12-03 | Banyu Pharmaceutical Co., Ltd. | Derives de 2-0xoimidazole |
JPH11228575A (ja) | 1997-12-05 | 1999-08-24 | F Hoffmann La Roche Ag | 1,3,8−トリアザ−スピロ〔4.5〕デカン−4−オン誘導体 |
WO1999036421A1 (en) | 1998-01-19 | 1999-07-22 | Pfizer Pharmaceuticals Inc. | 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists |
JP2000026466A (ja) | 1998-06-12 | 2000-01-25 | F Hoffmann La Roche Ag | ジ―又はトリアザ―スピロ〔4,5〕デカン誘導体 |
JP2003524634A (ja) * | 1999-12-06 | 2003-08-19 | ユーロ−セルティーク,エス.エイ. | ノシセプチン受容体親和性を有するベンズイミダゾール化合物 |
WO2001039775A1 (en) | 1999-12-06 | 2001-06-07 | Euro-Celtique, S.A. | Benzimidazole compounds having nociceptin receptor affinity |
WO2003082333A1 (fr) | 2002-03-29 | 2003-10-09 | Mitsubishi Pharma Corporation | Remede contre les troubles du sommeil |
WO2005028466A1 (en) | 2003-09-25 | 2005-03-31 | Solvay Pharmaceuticals B.V. | Benzimidazolone and quinazolinone derivatives as agonists on human orl1 receptors |
WO2006000545A1 (de) | 2004-06-23 | 2006-01-05 | Siemens Aktiengesellschaft | Aufbau einer verbindung für den austausch von daten eines ip-basierten dienstes |
JP2007051842A (ja) | 2005-08-19 | 2007-03-01 | Nippon Mizushori Giken:Kk | プラント洗浄方法,アスベスト除去方法および解体処理方法並びにミスト発生機 |
JP2007059260A (ja) | 2005-08-25 | 2007-03-08 | Toshiba Lighting & Technology Corp | 照明装置及び照明器具 |
JP2007078845A (ja) | 2005-09-12 | 2007-03-29 | Sharp Corp | 現像装置およびそれを備える画像形成装置 |
JP2007093846A (ja) | 2005-09-28 | 2007-04-12 | Sanyo Epson Imaging Devices Corp | 電気光学装置、および電子機器 |
Non-Patent Citations (29)
Title |
---|
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 6, 1996, pages 1641 |
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 9, 1999, pages 1537 |
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 9, 1999, pages 2343 |
BR. J. PHARMACOL., vol. 129, 2000, pages 1261 - 1283 |
CHEM. PHARM. BULL., vol. 37, 1989, pages 962 |
EUR. J. NEUROSCI., vol. 9, 1997, pages 194 - 197 |
EUR. J. PHARMACOL., vol. 340, 1997, pages 1 - 15 |
FEBS LETT., vol. 341, 1994, pages 33 - 38 |
FEBS LETT., vol. 347, 1994, pages 284 - 288 |
J. CHEM. SOC., 1954, pages 4299 |
J. CHEM. SOC., PERKIN TRANS, vol. 1, 1973, pages 1160 |
J. MED. CHEM., vol. 44, 2001, pages 3378 |
J. ORG. CHEM., vol. 55, 1990, pages 2552 - 54 |
J. ORG. CHEM., vol. 66, 2001, pages 919 |
NATURE, vol. 377, 1995, pages 532 - 535 |
NATURE, vol. 394, 1998, pages 577 - 581 |
NEUROREPORT, vol. 8, 1996, pages 369 - 371 |
ORG. LETT., vol. 8, 2006, pages 3311 |
ORG. SYNTH., 1943, pages 501 |
ORG. SYNTH., 1964, pages 34 |
ORGANIC FUNCTIONAL GROUP PREPARATIONS, vol. 3, 1972, pages 322 |
PHARMACOL. REV., vol. 53, 2001, pages 381 - 415 |
PROC. NATL. ACAD. SCI. U.S.A., vol. 97, 2000, pages 4938 - 4943 |
PROC. NATL. ACAD. SCI. USA, vol. 94, 1997, pages 14854 - 14858 |
PROC. NATL. ACAD. SCI. USA, vol. 96, 1999, pages 10444 - 10449 |
SCIENCE, vol. 270, 1995, pages 792 - 794 |
See also references of EP2128154A4 * |
SHIN JIKKEN KAGAKU KOZA, vol. 14, 1978, pages 1339 |
THE CHEMISTRY OF OPEN-CHAIN ORGANIC NITROGEN COMPOUNDS, vol. 2, 1966, pages L |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9278967B2 (en) | 2007-08-31 | 2016-03-08 | Purdue Pharma L.P. | Substituted-quinoxaline-type piperidine compounds and the uses thereof |
US9527840B2 (en) | 2007-08-31 | 2016-12-27 | Purdue Pharma L.P. | Substituted-quinoxaline-type piperidine compounds and the uses thereof |
JP2010537969A (ja) * | 2007-08-31 | 2010-12-09 | パーデュー、ファーマ、リミテッド、パートナーシップ | 置換キノキサリンタイプピペリジン化合物とその使用 |
EP2433935A1 (en) * | 2007-08-31 | 2012-03-28 | Purdue Pharma LP | Substituted-quinoxaline-type-piperidine compounds and the uses thereof |
EP2433937A1 (en) * | 2007-08-31 | 2012-03-28 | Purdue Pharma LP | Substituted-quinoxaline-type-piperidine compounds and the uses thereof |
EP2433936A1 (en) * | 2007-08-31 | 2012-03-28 | Purdue Pharma LP | Substituted-quinoxaline-type-piperidine compounds and the uses thereof |
WO2009027820A3 (en) * | 2007-08-31 | 2009-04-23 | Purdue Pharma Lp | Substituted-quinoxaline-type-piperidine compounds and the uses thereof |
EP3101018A1 (en) * | 2007-08-31 | 2016-12-07 | Purdue Pharma L.P. | Substituted-quinoxaline-type-piperidine compounds and the uses thereof |
US8846929B2 (en) | 2007-08-31 | 2014-09-30 | Purdue Pharma L.P. | Substituted-quinoxaline-type piperidine compounds and the uses thereof |
US8471032B2 (en) | 2008-09-16 | 2013-06-25 | Mitsubishi Tanabe Pharma Corporation | Benzimidazole compound in crystal form and salt thereof |
JP5236019B2 (ja) * | 2009-02-03 | 2013-07-17 | 田辺三菱製薬株式会社 | 1−(4−ピペリジニル)ベンゾイミダゾロン誘導体の製造方法 |
WO2010090198A1 (ja) | 2009-02-03 | 2010-08-12 | 田辺三菱製薬株式会社 | 1-(4-ピペリジニル)ベンゾイミダゾロン誘導体の製造方法 |
US9656994B2 (en) | 2013-03-22 | 2017-05-23 | The Scripps Research Institute | Substituted benzimidazoles as nociceptin receptor modulators |
JP2015010072A (ja) * | 2013-06-28 | 2015-01-19 | 三菱瓦斯化学株式会社 | テトラリン骨格を有する新規アルデヒド、およびその製造方法。 |
US10703765B2 (en) | 2014-06-02 | 2020-07-07 | Esteve Pharmaceuticals, S.A. | Alkyl and aryl derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against pain |
US10246465B2 (en) | 2014-06-02 | 2019-04-02 | Laboratorios Del Dr. Esteve S.A. | Alkyl derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against pain |
US10689398B2 (en) | 2015-10-23 | 2020-06-23 | Esteve Pharmaceuticals, S.A. | OXA-Diazaspiro compounds having activity against pain |
US10927128B2 (en) | 2015-11-16 | 2021-02-23 | Esteve Pharmaceuticals. S.A. | Oxadiazaspiro compounds for the treatment of drug abuse and addiction |
US11649248B2 (en) | 2015-11-16 | 2023-05-16 | Esteve Pharmaceuticals, S.A. | Oxadiazaspiro compounds for the treatment of drug abuse and addiction |
KR20190092464A (ko) | 2016-11-28 | 2019-08-07 | 미쓰비시 타나베 파마 코퍼레이션 | 코카인 의존증의 치료 또는 재발 예방약 |
JPWO2018097291A1 (ja) * | 2016-11-28 | 2019-10-17 | 田辺三菱製薬株式会社 | コカイン依存症の治療または再発予防薬 |
WO2018097291A1 (ja) | 2016-11-28 | 2018-05-31 | 田辺三菱製薬株式会社 | コカイン依存症の治療または再発予防薬 |
US11058674B2 (en) | 2016-11-28 | 2021-07-13 | Mitsubishi Tanabe Pharma Corporation | Drug for treating cocaine addiction or preventing recurrence of same |
US11236110B2 (en) | 2017-10-17 | 2022-02-01 | Esteve Pharmaceuticals, S.A. | Salts of (R)-9-(2,5-difluorophenethyl)-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one |
Also Published As
Publication number | Publication date |
---|---|
EP2128154A4 (en) | 2011-01-26 |
ES2541133T3 (es) | 2015-07-16 |
EP2128154A1 (en) | 2009-12-02 |
CN101622241A (zh) | 2010-01-06 |
CA2679530C (en) | 2012-09-25 |
JPWO2008105497A1 (ja) | 2010-06-03 |
US8877779B2 (en) | 2014-11-04 |
CN101622241B (zh) | 2013-05-22 |
KR101165504B1 (ko) | 2012-07-13 |
JP2013107910A (ja) | 2013-06-06 |
KR20090115976A (ko) | 2009-11-10 |
CA2679530A1 (en) | 2008-09-04 |
US20100120841A1 (en) | 2010-05-13 |
JP5313865B2 (ja) | 2013-10-09 |
MX2009009355A (es) | 2009-09-11 |
AU2008219980B2 (en) | 2012-01-12 |
BRPI0808025A2 (pt) | 2014-06-24 |
EP2128154B1 (en) | 2015-04-08 |
AU2008219980A1 (en) | 2008-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008105497A1 (ja) | ベンゾイミダゾール化合物およびその医薬用途 | |
WO2009030469A8 (en) | Fungicidal 2-alkylthio-2-quinolinyloxy-acetamide deritvatives | |
WO2008153154A1 (ja) | 環状化合物、フォトレジスト基材及びフォトレジスト組成物 | |
WO2008101187A3 (en) | Pro-drugs of peripheral phenolic opioid antagonists | |
WO2007125547A3 (en) | Novel process for statins and its pharmaceutically acceptable salts thereof | |
WO2011055933A3 (ko) | 유기광전소자용 조성물, 이를 이용한 유기광전소자 및 이를 포함하는 표시장치 | |
WO2008110355A8 (en) | Quinoline derivatives as fungicides | |
WO2008096829A1 (ja) | 3環系化合物 | |
WO2009049716A8 (en) | Novel fungicides | |
WO2007003962A3 (en) | Gpcr agonists | |
WO2007003961A3 (en) | Gpcr agonists | |
WO2007092642A3 (en) | Polymer formulations of cetp inhibitors | |
WO2009019015A8 (en) | Novel herbicides | |
WO2009156462A3 (en) | Organic compounds | |
WO2008005368A3 (en) | Piperazines as p2x7 antagonists | |
TN2010000148A1 (en) | Amide compound | |
WO2009024342A3 (en) | Novel microbiocides | |
WO2005121078A3 (de) | Substituierte cyclopenten-verbindungen | |
WO2011081285A3 (ko) | 레지스트 하층막용 방향족 고리 함유 중합체 및 이를 포함하는 레지스트 하층막 조성물 | |
RS52255B (en) | NALMEFEN HYDROCHLORIDE DIHYDRATE | |
WO2006039250A3 (en) | Chemokine-binding heterocyclic compound salts, and methods of use thereof | |
WO2008151828A8 (en) | Novel microbiocides | |
WO2009153461A3 (fr) | Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro-2h-3- benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable | |
WO2009113092A3 (en) | Process for preparation of proguanil hydrochloride | |
WO2009127718A3 (en) | Novel microbiocides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200880006831.2 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08712095 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009501298 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12009501639 Country of ref document: PH |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2679530 Country of ref document: CA Ref document number: MX/A/2009/009355 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12449874 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008712095 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008219980 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020097020508 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009136344 Country of ref document: RU Ref document number: 5796/CHENP/2009 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2008219980 Country of ref document: AU Date of ref document: 20080228 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: PI0808025 Country of ref document: BR Kind code of ref document: A2 Effective date: 20090831 |